Diligence memo · auto-generated · as of July 2, 2026
Evommune, Inc.
Evommune, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Evommune, Inc. operates in Other, based in PALO ALTO.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Evommune, Inc. has raised $267M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $115M on 2024-10-30.
Most recent recorded round closed around 2024-10-30.
Valuation (modeled)modeled
Provath models Evommune, Inc. at approximately $1.0B (range $654M–$1.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.77× the median modeled value of Series D+ Other companies in 2022–2024 (109 peers) — value vs value, same stage and era. Within the normal band (77% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 17 months.
Last raise 20 mo ago; this sector typically re-raises about every 11 months.
Slightly overdue versus sector cadence.
The last round stepped up 2.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 99% of Other peers (25015 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: Getaround, Inc, Relentless Topco, Inc., NQ PE Project Colosseum Parent, L.P., Cowboy Topco, Inc., Office Topco, Llc.
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.